Baker Bros. Advisors as of March 31, 2013
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 71 positions in its portfolio as reported in the March 2013 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Synergy Pharmaceuticals | 3.0 | $9.9M | 1.6M | 6.07 | |
Chelsea Therapeutics International | 2.9 | $9.7M | 4.8M | 2.04 | |
Medivation 2.625% 4/1/17 conv bonds | 2.7 | $9.1M | 40M | 0.23 | |
Gilead Sciences (GILD) | 2.7 | $9.0M | 184k | 48.94 | |
Exelisis 4.25% 8/15/2019 conv bonds | 2.7 | $8.9M | 19M | 0.47 | |
Ariad Pharmaceuticals | 2.6 | $8.9M | 2.2M | 4.13 | |
Cerus | 2.6 | $8.9M | 6.5M | 1.36 | |
Biomarin Pharmaceuticals | 2.6 | $8.8M | 783k | 11.19 | |
Clovis Oncology | 2.6 | $8.7M | 1.0M | 8.69 | |
Pharmacyclics | 2.5 | $8.4M | 11M | 0.77 | |
23 Halozyme Therapeutics | 2.5 | $8.3M | 3.2M | 2.62 | |
Vanda Pharmaceuticals (VNDA) | 2.3 | $7.6M | 1.9M | 3.92 | |
55 Intermune Inc Notes 5% 3/1/15 conv bonds | 2.3 | $7.6M | 17M | 0.45 | |
XenoPort | 2.2 | $7.4M | 1.0M | 7.15 | |
Array BioPharma | 2.2 | $7.4M | 1.5M | 4.91 | |
Threshold Pharma | 2.2 | $7.4M | 1.6M | 4.61 | |
BioDelivery Sciences International | 2.1 | $7.2M | 1.7M | 4.21 | |
Infinity Pharmaceuticals | 2.1 | $7.1M | 1.2M | 6.04 | |
Incyte | 2.0 | $6.7M | 15M | 0.45 | |
Gilead 1.625% 5/1/16 conv bonds | 2.0 | $6.7M | 22M | 0.31 | |
BioCryst Pharmaceuticals (BCRX) | 2.0 | $6.6M | 5.6M | 1.19 | |
Synageva Biopharma | 1.9 | $6.5M | 9.2M | 0.71 | |
Auxilium | 1.9 | $6.5M | 2.1M | 3.06 | |
Derma Sciences | 1.9 | $6.4M | 1.4M | 4.72 | |
Repros Therapeutics | 1.9 | $6.4M | 2.3M | 2.83 | |
Insmed (INSM) | 1.8 | $6.0M | 796k | 7.49 | |
Seattle Genetics | 1.8 | $6.0M | 19M | 0.31 | |
Intermune | 1.7 | $5.7M | 1.7M | 3.29 | |
D Stemline Therapeutics | 1.7 | $5.7M | 500k | 11.41 | |
Genomic Health | 1.7 | $5.7M | 13M | 0.45 | |
Anacor Pharmaceuticals | 1.5 | $5.0M | 777k | 6.46 | |
Medivation | 1.5 | $5.0M | 535k | 9.37 | |
Progenics Pharmaceuticals | 1.4 | $4.8M | 900k | 5.38 | |
Aegerion Pharmaceuticals | 1.4 | $4.8M | 864k | 5.61 | |
United Therapeutics Notes 1% 9/15/16 144a conv bonds | 1.4 | $4.7M | 18M | 0.26 | |
Viropharma | 1.4 | $4.6M | 8.5M | 0.54 | |
Mei Pharma | 1.3 | $4.3M | 500k | 8.63 | |
Onyx Pharmaceuticals | 1.2 | $4.2M | 160k | 26.23 | |
Acadia Pharmaceuticals | 1.2 | $4.1M | 16M | 0.26 | |
Kythera Biopharmaceuticals I | 1.2 | $4.0M | 165k | 24.36 | |
Intercept Pharmaceuticals In | 1.2 | $4.0M | 375k | 10.73 | |
Achillion Pharmaceuticals | 1.2 | $4.0M | 455k | 8.75 | |
Gilead 0.625% 5/1/13 conv bonds | 1.2 | $4.0M | 25M | 0.16 | |
Vertex Pharmaceuticals | 1.1 | $3.9M | 252k | 15.35 | |
AVEO Pharmaceuticals | 1.1 | $3.8M | 520k | 7.35 | |
54 Intermune Inc Notes 2.5% 9/15/18 conv bonds | 1.1 | $3.8M | 17M | 0.23 | |
INC Ventrus Biosciences | 1.1 | $3.6M | 1.2M | 2.99 | |
Zogenix | 1.1 | $3.6M | 2.0M | 1.80 | |
Qlt | 1.1 | $3.6M | 1.5M | 2.33 | |
Ironwood Pharmaceuticals | 0.8 | $2.8M | 698k | 3.96 | |
Cytrx | 0.8 | $2.7M | 1.0M | 2.72 | |
Synta Pharmaceuticals | 0.8 | $2.6M | 1.5M | 1.76 | |
Intermune Inc Notes 2.5% 12/15/17 conv bonds | 0.7 | $2.5M | 41M | 0.06 | |
ArQule | 0.7 | $2.4M | 910k | 2.59 | |
Salix Pharmaceuticals | 0.7 | $2.2M | 44k | 51.17 | |
Ligand Pharmaceuticals | 0.6 | $2.0M | 73k | 26.65 | |
Discovery Laboratories | 0.6 | $2.0M | 853k | 2.29 | |
Amicus Therapeutics (FOLD) | 0.5 | $1.6M | 515k | 3.17 | |
Biodel | 0.5 | $1.5M | 540k | 2.84 | |
Prothena (PRTA) | 0.4 | $1.3M | 192k | 6.69 | |
Questcor Pharmaceuticals | 0.3 | $1.1M | 342k | 3.26 | |
Geron Corporation (GERN) | 0.3 | $1.1M | 1.0M | 1.07 | |
Lpath | 0.3 | $1.0M | 200k | 5.02 | |
Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 conv bonds | 0.3 | $916k | 23M | 0.04 | |
Xoma | 0.2 | $811k | 20M | 0.04 | |
Chemocentryx | 0.2 | $691k | 50k | 13.82 | |
Tesaro | 0.2 | $686k | 31k | 21.97 | |
ZIOPHARM Oncology | 0.1 | $465k | 254k | 1.83 | |
Cubist Pharmaceuticals | 0.1 | $234k | 5.0k | 46.80 | |
Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.1 | $207k | 21k | 9.87 | |
Aradigm Corporation (ARDM) | 0.0 | $13k | 100k | 0.13 |